Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reaso

INDIANAPOLIS , July 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the s

INDIANAPOLIS , July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Verve Therapeutic

Investing in biotechnology stocks is similar to the drug development process itself. That is, invest

Shares in Verve Therapeutics (VERV -0.54%) soared 80.5% this week on the news of an agreement for El

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

LLY's move to buy Verve ignites investor interest across gene-editing stocks like CRSP, NTLA and BEA

VERV jumps on Eli Lilly's buyout offer, adding next-gen gene-editing therapies to the pharma giant's

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Shares of Verve Therapeutics (VERV 76.24%) were skyrocketing 75.7% higher as of 10:50 a.m. ET on Tue

Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check amid

Verve Therapeutics stock nearly doubled Tuesday after Eli Lilly agreed to buy the gene-editing compa

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Verve (Nasdaq: VERV) for possible breach

Eli Lilly agreed to acquire Verve Therapeutics for approximately $1 billion up front, adding a poten

Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday.

Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by

A report said the two pharmaceutical companies are in advance talks.

Eli Lilly and Co (NYSE:LLY) is in advanced discussions to acquire Verve Therapeutics in a deal worth

Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 bil